Schedule 13G ownership disclosure

NEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 64052L106

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,962,657
Percent of class
9.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000125
Form type
SC 13G/A
Filer
Neos Therapeutics, Inc.
CIK
CIK 1467652
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub